Keith L. Knutson
Affiliations: | Immunology | College of Medicine - Mayo Clinic |
Area:
Immunology, Cell BiologyGoogle:
"Keith Knutson"Children
Sign in to add trainee| Jennifer M. Reiman | grad student | 2010 | College of Medicine - Mayo Clinic |
| Andrea M. Henle | grad student | 2012 | College of Medicine - Mayo Clinic |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Luo Y, Shreeder B, Jenkins JW, et al. (2023) Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade. Journal For Immunotherapy of Cancer. 11 |
| Carter JM, Chumsri S, Hinerfeld DA, et al. (2023) Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer. Nature Communications. 14: 2215 |
| Ogony J, Hoskin TL, Stallings-Mann M, et al. (2022) Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers. Breast Cancer Research and Treatment |
| Sammons S, Raskina K, Danziger N, et al. (2022) APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy. Jco Precision Oncology. 6: e2200149 |
| Vivekanandhan S, Knutson KL. (2022) Resistance to Trastuzumab. Cancers. 14 |
| Block MS, Dietz AB, Gustafson MP, et al. (2020) Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients. Nature Communications. 11: 5173 |
| Gabriel EM, Kim M, Fisher DT, et al. (2020) Dynamic control of tumor vasculature improves antitumor responses in a regional model of melanoma. Scientific Reports. 10: 13245 |
| Ogony JW, Radisky DC, Ruddy KJ, et al. (2020) Immune Responses and Risk of Triple Negative Breast Cancer: Implications for Higher Rates among African American women. Cancer Prevention Research (Philadelphia, Pa.) |
| Ren Y, Cherukuri Y, Wickland DP, et al. (2020) HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer. Oncoimmunology. 9: 1744947 |
| Zamarin D, Walderich S, Holland A, et al. (2020) Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: a phase II trial. Journal For Immunotherapy of Cancer. 8 |